To evaluate the efficacy of Vatsadani Kwath in the treatment of Vatrakta (Gout)
Phase 3
Completed
- Conditions
- Health Condition 1: M109- Gout, unspecified
- Registration Number
- CTRI/2023/04/051350
- Lead Sponsor
- DEPARTMENT OF KAYACHIKITSA COLLEGE OF AYURVED BHARTI VIDYAPEETH DEEMED TO BE UNIVERSITY
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
•Patients of age between 18-70 years of either sex.
•Patients having classical sign and symptoms of Uttan vatarakta .
•Patients with serum uric acid level more than 7mg/dl(male) and more than 6mg/dl (female) with associate features like joint pain and inflammation.
Exclusion Criteria
•More than 3 years chronicity.
• Patients suffering from chronic hepatic disease, renal disease.
•Patients of Uttan Vatrakta associated with any of following disorder will be excluded from study such as- Rheumatoid arthritis, Auto immune disease.
•Any other inflammatory disorder like tubercular arthritis, septic arthritis.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in Sr. Uric Acid levels.Timepoint: 1 MONTH
- Secondary Outcome Measures
Name Time Method Reduction in Signs and Symptoms of vatrakta ( reduction in the subjective parameters that in reduction in sandhi shoola, sandhi shotha, sparsh ashayta, raga, tavakvaivarnyta vidaha, stabhdata, chimchimayan. Improvement in VAS scale.Timepoint: 28 Days